{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:32:55Z","timestamp":1791646375716,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00405-026-10298-6","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:15:29Z","timestamp":1777997729000},"page":"5065-5074","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Switching to dupilumab from other biologic therapies in chronic rhinosinusitis with nasal polyps (CRSWNP): a comparison with biologic-na\u00efve patients"],"prefix":"10.1007","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3341-5926","authenticated-orcid":false,"given":"Daniela","family":"Lucidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Seccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Mastrapasqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Dallari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Alicandri-Ciufelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio Javier","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Pipolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Fadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Garzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Dell\u2019Era","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Carriera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Puxeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Menzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampietro","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"De Corso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"issue":"10","key":"10298_CR1","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.3390\/jcm12103371","volume":"12","author":"C Pelaia","year":"2023","unstructured":"Pelaia C, Pelaia G, Maglio A et al (2023) Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis. J Clin Med 12(10):3371. https:\/\/doi.org\/10.3390\/jcm12103371. Published 2023 May 9","journal-title":"J Clin Med"},{"key":"10298_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2020.1815682","author":"S Chen","year":"2020","unstructured":"Chen S, Zhou A, Emmanuel B, Thomas K, Guiang H (2020) Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis. Curr Med Res Opin. https:\/\/doi.org\/10.1080\/03007995.2020.1815682","journal-title":"Curr Med Res Opin"},{"key":"10298_CR3","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.600","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens WJ et al (2020) European position paper on rhinosinusitis and nasal polyps. Dieudonn\u00e9 Nyenbue Tshipukane. https:\/\/doi.org\/10.4193\/Rhin20.600","journal-title":"Dieudonn\u00e9 Nyenbue Tshipukane"},{"issue":"3","key":"10298_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/alr.22741","volume":"11","author":"RR Orlandi","year":"2021","unstructured":"Orlandi RR et al (2021) International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol 11(3):213\u2013739. https:\/\/doi.org\/10.1002\/alr.22741","journal-title":"Int Forum Allergy Rhinol"},{"key":"10298_CR5","doi-asserted-by":"publisher","first-page":"105947","DOI":"10.1016\/j.rmed.2020.105947","volume":"166","author":"GW Canonica","year":"2020","unstructured":"Canonica GW, Malvezzi L, Blasi F et al (2020) Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry. Respir Med 166:105947. https:\/\/doi.org\/10.1016\/j.rmed.2020.105947","journal-title":"Respir Med"},{"key":"10298_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013513.pub2","author":"LY Chong","year":"2020","unstructured":"Chong LY et al (2020) Biologics for chronic rhinosinusitis. Cochrane Database Syst Rev https:\/\/doi.org\/10.1002\/14651858.CD013513.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10298_CR7","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1007\/s00405-024-08461-y","volume":"281","author":"C Rosso","year":"2024","unstructured":"Rosso C, De Corso E, Conti V et al (2024) Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP. Eur Arch Otorhinolaryngol 281(6):3017\u20133023. https:\/\/doi.org\/10.1007\/s00405-024-08461-y","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"10298_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4193\/Rhin23.415","volume":"62","author":"WJ Fokkens","year":"2024","unstructured":"Fokkens WJ, De Corso E, Backer V et al (2024) EPOS2020\/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP. Rhinology 62(3):287\u2013298. https:\/\/doi.org\/10.4193\/Rhin23.415","journal-title":"Rhinology"},{"key":"10298_CR9","doi-asserted-by":"publisher","unstructured":"De Corso E, Montuori C, Pipolo C et al (2025) Two-year turning point with dupilumab in CRSwNP: control, remission, and tapering dosage. Allergy Published online August 30. https:\/\/doi.org\/10.1111\/all.70032","DOI":"10.1111\/all.70032"},{"issue":"1","key":"10298_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14639\/0392-100X-N1614","volume":"42","author":"E De Corso","year":"2022","unstructured":"De Corso E, Bellocchi G, De Benedetto M et al (2022) Biologics for severe uncontrolled chronic rhinosinusitis with nasal polyps: a change management approach. Consensus of the Joint Committee of Italian Society of Otorhinolaryngology on biologics in rhinology. Acta Otorhinolaryngol Ital 42(1):1\u201316. https:\/\/doi.org\/10.14639\/0392-100X-N1614","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"10209","key":"10298_CR11","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","volume":"394","author":"C Bachert","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M et al (2019) Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 394(10209):1638\u20131650. https:\/\/doi.org\/10.1016\/S0140-6736(19)31881-1","journal-title":"Lancet"},{"issue":"5","key":"10298_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.14639\/0392-100X-A973","volume":"45","author":"E De Corso","year":"2025","unstructured":"De Corso E, Vaghi A, Corb\u00f2 M et al (2025) Optimising care for chronic rhinosinusitis with nasal polyps and asthma in multimorbid patients: a multidisciplinary Delphi consensus. Acta Otorhinolaryngol Ital 45(5):339\u2013348. https:\/\/doi.org\/10.14639\/0392-100X-A973","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"12","key":"10298_CR13","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1111\/all.13875","volume":"74","author":"WJ Fokkens","year":"2019","unstructured":"Fokkens WJ et al (2019) EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy 74(12):2312. https:\/\/doi.org\/10.1111\/all.13875","journal-title":"Allergy"},{"issue":"6","key":"10298_CR14","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.jaip.2021.01.031","volume":"9","author":"AT Peters","year":"2021","unstructured":"Peters AT, Han JK, Hellings P et al (2021) Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract 9(6):2461\u20132471e5. https:\/\/doi.org\/10.1016\/j.jaip.2021.01.031","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10298_CR15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","volume":"146","author":"P Gevaert","year":"2020","unstructured":"Gevaert P et al (2020) Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol 146(3):595\u2013605. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.032","journal-title":"J Allergy Clin Immunol"},{"key":"10298_CR16","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.570","author":"L Ren","year":"2019","unstructured":"Ren L, Zhang N, Zhang L, Bachert C (2019) Biologics for the treatment of chronic rhinosinusitis with nasal polyps\u2014state of the art. World Allergy Organ J. https:\/\/doi.org\/10.4193\/Rhin20.570","journal-title":"World Allergy Organ J"},{"issue":"10","key":"10298_CR17","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1007\/s00405-024-08738-2","volume":"281","author":"U Tanzini","year":"2024","unstructured":"Tanzini U, Rampi A, Vinciguerra A et al (2024) Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps. Eur Arch Otorhinolaryngol 281(10):5285\u20135292. https:\/\/doi.org\/10.1007\/s00405-024-08738-2","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"12","key":"10298_CR18","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S2213-2600(25)00287-5","volume":"13","author":"E De Corso","year":"2025","unstructured":"De Corso E, Canonica GW, Heffler E et al (2025) Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial. Lancet Respir Med 13(12):1067\u20131077. https:\/\/doi.org\/10.1016\/S2213-2600(25)00287-5","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10298_CR19","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1007\/s00405-025-09559-7","volume":"282","author":"T Alharbi","year":"2025","unstructured":"Alharbi T, Alsubaie N, Alroqi A (2025) An overview of switching biological therapies for chronic rhinosinusitis with nasal polyposis (CRSwNP). Eur Arch Otorhinolaryngol 282(12):6057\u20136068. https:\/\/doi.org\/10.1007\/s00405-025-09559-7","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"10","key":"10298_CR20","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/jpm15100471","volume":"15","author":"C Gonzalez-Lluch","year":"2025","unstructured":"Gonzalez-Lluch C, Basaga\u00f1a M, Pardo L et al (2025) Comorbidities as a Personalized Target in Patients with Severe Asthma Treated with Dupilumab. J Pers Med 15(10):471 Published 2025 Oct 2. https:\/\/doi.org\/10.3390\/jpm15100471","journal-title":"J Pers Med"},{"issue":"3","key":"10298_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4193\/Rhin22.489","volume":"61","author":"WJ Fokkens","year":"2023","unstructured":"Fokkens WJ, Viskens AS, Backer V et al (2023) EPOS\/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023. Rhinology 61(3):194\u2013202. https:\/\/doi.org\/10.4193\/Rhin22.489","journal-title":"Rhinology"},{"issue":"2","key":"10298_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/alr.23466","volume":"15","author":"M Dorling","year":"2025","unstructured":"Dorling M, Sarafan M, Voizard B et al (2025) Switching biologics in chronic rhinosinusitis with nasal polyps: A multicenter Canadian experience. Int Forum Allergy Rhinol 15(2):166\u2013173. https:\/\/doi.org\/10.1002\/alr.23466","journal-title":"Int Forum Allergy Rhinol"},{"issue":"10","key":"10298_CR23","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1111\/all.15772","volume":"78","author":"E De Corso","year":"2023","unstructured":"De Corso E, Pasquini E, Trimarchi M et al (2023) Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL). Allergy 78(10):2669\u20132683. https:\/\/doi.org\/10.1111\/all.15772","journal-title":"Allergy"},{"issue":"3","key":"10298_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00405-006-0173-0","volume":"264","author":"T Hummel","year":"2007","unstructured":"Hummel T, Kobal G, Gudziol H, Mackay-Sim A (2007) Normative data for the Sniffin\u2019 Sticks including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 264(3):237\u2013243. https:\/\/doi.org\/10.1007\/s00405-006-0173-0","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"10298_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhino16.248","volume":"56","author":"T Hummel","year":"2016","unstructured":"Hummel T, Whitcroft KL, Andrews P et al (2016) Position paper on olfactory dysfunction. Rhinology 56(1):1\u201330. https:\/\/doi.org\/10.4193\/Rhino16.248","journal-title":"Rhinology"},{"issue":"2","key":"10298_CR26","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00405-016-4313-x","volume":"274","author":"F Mozzanica","year":"2017","unstructured":"Mozzanica F, Preti A, Gera R et al (2017) Cross-cultural adaptation and validation of the SNOT-22 into Italian. Eur Arch Otorhinolaryngol 274(2):887\u2013895. https:\/\/doi.org\/10.1007\/s00405-016-4313-x","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"10298_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11882-024-01135-z","volume":"24","author":"E De Corso","year":"2024","unstructured":"De Corso E, Pipolo C, Caminati M et al (2024) Multidisciplinary Decision-Making-ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study). Curr Allergy Asthma Rep 24(3):143\u2013154. https:\/\/doi.org\/10.1007\/s11882-024-01135-z","journal-title":"Curr Allergy Asthma Rep"},{"key":"10298_CR28","doi-asserted-by":"publisher","unstructured":"Bagnasco D, Bondi B, Brussino L et al (2025) Dupilumab effectiveness in patients with severe allergic asthma non-responsive to omalizumab. J Pers Med. ;15(2):43. Published 2025 Jan 23. https:\/\/doi.org\/10.3390\/jpm15020043","DOI":"10.3390\/jpm15020043"},{"issue":"3","key":"10298_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/ACI.0000000000001067","volume":"25","author":"B Abdullah","year":"2025","unstructured":"Abdullah B, Zahedi FD, Tantilipikorn P (2025) From one biologic to another: the rationale and evidence behind switching therapies in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol 25(3):144\u2013150. https:\/\/doi.org\/10.1097\/ACI.0000000000001067","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"10298_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4193\/Rhin22.408","volume":"61","author":"FF Brkic","year":"2023","unstructured":"Brkic FF, Liu DT, Klimbacher R et al (2023) Efficacy and safety of switching between biologics in chronic rhinosinusitis with nasal polyps or N-ERD. Rhinology 61(4):320\u2013327. https:\/\/doi.org\/10.4193\/Rhin22.408","journal-title":"Rhinology"},{"issue":"8","key":"10298_CR31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1080\/1744666X.2023.2218617","volume":"19","author":"J Otten","year":"2023","unstructured":"Otten J, van der Lans R, de Corso E et al (2023) Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making. Expert Rev Clin Immunol 19(8):1041\u20131049. https:\/\/doi.org\/10.1080\/1744666X.2023.2218617","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"10298_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.14639\/0392-100X-N1911","volume":"42","author":"L Nitro","year":"2022","unstructured":"Nitro L, Bulfamante AM, Rosso C et al (2022) Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review. Acta Otorhinolaryngol Ital 42(3):199\u2013204. https:\/\/doi.org\/10.14639\/0392-100X-N1911","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"1","key":"10298_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18787\/jr.2025.00002","volume":"32","author":"KI Lee","year":"2025","unstructured":"Lee KI, Ryu G, Yoo SH et al (2025) Biologics for Chronic Rhinosinusitis With Nasal Polyps: Current Status and Clinical Considerations in Korea. J Rhinol 32(1):1\u20139. https:\/\/doi.org\/10.18787\/jr.2025.00002","journal-title":"J Rhinol"},{"key":"10298_CR34","doi-asserted-by":"publisher","unstructured":"Caminati M, Portacci A, Cefaloni F et al (2026) When hypereosinophilia occurs during dupilumab therapy: evidence-based strategies for clinical management in respiratory indications. Expert Rev Respir Med. Published online January 1. https:\/\/doi.org\/10.1080\/17476348.2025.2604322","DOI":"10.1080\/17476348.2025.2604322"},{"key":"10298_CR35","doi-asserted-by":"publisher","unstructured":"De Corso E, Montuori C, Pasquini E et al (2025) Dupilumab-induced blood eosinophilia in patients with chronic rhinosinusitis with nasal polyps: temporal trends and correlation with adverse events. J Allergy Clin Immunol Pract Published online Oct 31. https:\/\/doi.org\/10.1016\/j.jaip.2025.10.032","DOI":"10.1016\/j.jaip.2025.10.032"},{"issue":"6","key":"10298_CR36","doi-asserted-by":"publisher","first-page":"768","DOI":"10.4193\/Rhin25.266","volume":"63","author":"E De Corso","year":"2025","unstructured":"De Corso E, Caminati M, Hellings PW et al (2025) Clinical management of dupilumab-induced blood eosinophilia in CRSwNP: a practical algorithm. Rhinology 63(6):768\u2013770. https:\/\/doi.org\/10.4193\/Rhin25.266","journal-title":"Rhinology"},{"issue":"1","key":"10298_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11882-025-01246-1","volume":"26","author":"E De Corso","year":"2026","unstructured":"De Corso E, Canevari FRM, Caminati M et al (2026) Chronic Rhinosinusitis Optimisation of Nasal Outcomes and Scores (CHRONOS): An Italian Delphi Consensus on Long-Term Management with Biologics. Curr Allergy Asthma Rep 26(1):3. https:\/\/doi.org\/10.1007\/s11882-025-01246-1. Published 2026 Jan 9","journal-title":"Curr Allergy Asthma Rep"},{"key":"10298_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13223-019-0348-z","volume":"15","author":"H Ortega","year":"2019","unstructured":"Ortega H, Lemiere C, Llanos JP et al (2019) Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial. Allergy Asthma Clin Immunol 15:37 Published 2019 Jun 10. https:\/\/doi.org\/10.1186\/s13223-019-0348-z","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10298_CR39","doi-asserted-by":"publisher","unstructured":"Moore WC, Kornmann O, Humbert M et al (2022) Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study). Eur Respir J 59(1):2100396. Published 2022 Jan 6. https:\/\/doi.org\/10.1183\/13993003.00396-2021","DOI":"10.1183\/13993003.00396-2021"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10298-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10298-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10298-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:03:38Z","timestamp":1785517418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-026-10298-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10298"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10298-6","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}